Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 08, 2018

SELL
$7.16 - $10.05 $97,376 - $136,680
-13,600 Closed
0 $0
Q1 2018

May 10, 2018

SELL
$7.95 - $11.65 $23,850 - $34,950
-3,000 Reduced 18.07%
13,600 $108,000
Q4 2017

Feb 12, 2018

SELL
$9.65 - $12.65 $134,135 - $175,835
-13,900 Reduced 45.57%
16,600 $185,000
Q3 2017

Nov 13, 2017

BUY
$8.0 - $11.6 $244,000 - $353,800
30,500
30,500 $353,000

Others Institutions Holding ALPN

About ALPINE IMMUNE SCIENCES, INC.


  • Ticker ALPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,006,700
  • Description
  • Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...
More about ALPN
Track This Portfolio

Track Spark Investment Management LLC Portfolio

Follow Spark Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spark Investment Management LLC with notifications on news.